Search Virginia Mason News
VM to Host Pancreatic Cancer Symposium May 2
WHAT: Virginia Mason Medical Center will host the 2008 Pancreatic Cancer Symposium—Seattle, presented by the Pancreatic Cancer Action Network. Participants will hear from leading experts about pancreatic cancer, available treatment options, clinical trials, diet and nutrition, genetics and more. WHEN: May 2, 2008 from 8:30 a.m. to 5 p.m.
WHERE: Virginia Mason Medical Center, Lindeman Pavilion, Volney Richmond Auditorium, 1201 Terry Avenue, Seattle WHO: The free educational event for patients, survivors, caregivers, families and friends is open to the public. To register, visit www.pancan.org or call 877-272-6226. Space is limited. SPEAKERS: Current Diagnostic Tools
- Joo Ha Hwang, MD, University of Washington Medical Center
FDA-Approved Treatments and Their Side Effects
- Sam Whiting, MD, Seattle Cancer Care Alliance
Side-Effect Management Through Diet and Nutrition
- Maria Petzel, RD, LD, CNSD, MD, Anderson Cancer Center
- Vincent Picozzi, MD, Virginia Mason Medical Center
Management of Pain and Other Symptoms
- Amy Guthrie, MSN, APRN, BC-PCM, Oregon Health & Science University
A Balanced Approach to Surgery for Pancreatic Cancer
- William Traverso, MD, Virginia Mason Medical Center
Supporting the Caregiver
- Sylvia Farias, MSW, LICSW, Swedish Medical Center
Cutting Edge of Pancreatic Cancer Research
- Sunil Hingorani, MD, PhD, Fred Hutchinson Cancer Research Center
Nutrition Management Following Pancreatic Surgery
- Natalie Ledesma, MS, RD, University of California at San Francisco
Genetics of Pancreatic Cancer
- Brett Sheppard, MD, Oregon Health & Science University
SPONSORS: The Pancreatic Cancer Symposium-Seattle is made possible through educational grants from Genentech/OSI BioOncology and Lilly oncology.
PRESENTER: The Pancreatic Cancer Action Network is the only national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization raises money for direct private funding of research-and advocates for more aggressive federal research funding of medical breakthroughs in prevention, diagnosis and treatment of pancreatic cancer.